Loading…
Bhagiradha Chemicals & Industries (BHAGCHEM)₹189.03−2.95%Pesticides & Agrochemicals
In the Jun 2026 quarter (consolidated), Bhagiradha Chemicals & Industries reported sales of ₹195 Cr, up 57.3% from Jun 2025, and net profit of ₹12.97 Cr, up 225.1% year on year. For the year to Mar 2026, sales were ₹537 Cr and net profit ₹17.95 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 122 | 74.09 | 111 | 111 | 104 | 103 | 123 | 124 | 140 | 114 | 158 | 195 |
| Expenses | 109 | 65.96 | 96.97 | 98.91 | 94.02 | 93.94 | 117 | 115 | 125 | 99.91 | 139 | 164 |
| Operating Profit | 12.99 | 8.01 | 13.99 | 12.01 | 9.99 | 9.01 | 5.99 | 9.01 | 14.99 | 13.99 | 19.01 | 30.99 |
| OPM % | 11.1% | 11.0% | 13.0% | 11.0% | 9.0% | 9.0% | 5.0% | 7.0% | 11.0% | 12.0% | 12.0% | 16.0% |
| Other Income | 0.00 | 0.99 | 0.99 | 1.99 | 2.99 | 1.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.99 | 1.99 |
| Interest | 1.99 | 1.99 | 1.99 | 0.99 | 1.99 | 1.99 | 1.99 | 2.99 | 3.99 | 2.99 | 6.98 | 5.98 |
| Depreciation | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 4.01 | 4.01 | 4.01 | 4.01 | 5.02 | 8.02 | 8.02 |
| Profit before tax | 8.97 | 4.98 | 10.96 | 9.97 | 7.96 | 5.98 | 1.99 | 1.99 | 7.97 | 5.97 | 4.98 | 17.93 |
| Tax % | 33.1% | 31.1% | 32.0% | 41.0% | 30.0% | 35.1% | 140.0% | −59.0% | 27.0% | 27.0% | 15.0% | 24.1% |
| Net Profit | 5.98 | 2.99 | 6.99 | 5.98 | 4.98 | 3.99 | −0.99 | 3.99 | 5.98 | 4.99 | 3.99 | 12.97 |
| EPS (Rs) | 0.56 | 0.33 | 0.70 | 0.47 | 0.45 | 0.30 | −0.08 | 0.32 | 0.43 | 0.37 | 0.32 | 1.04 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 246 | 319 | 436 | 503 | 408 | 440 | 537 | 608 |
| Expenses | 229 | 271 | 367 | 425 | 365 | 404 | 479 | 528 |
| Operating Profit | 16.99 | 47.03 | 67.99 | 77.01 | 42.99 | 36.99 | 57.02 | 78.98 |
| OPM % | 7.0% | 15.1% | 16.0% | 15.0% | 11.0% | 8.0% | 11.0% | 13.0% |
| Other Income | 3.99 | 1.99 | 0.99 | 0.99 | 2.99 | 8.98 | 1.99 | 3.97 |
| Interest | 4.98 | 7.98 | 8.96 | 4.98 | 7.97 | 6.97 | 16.95 | 19.94 |
| Depreciation | 7.02 | 8.02 | 9.03 | 10.04 | 11.02 | 14.04 | 21.06 | 25.07 |
| Profit before tax | 8.97 | 31.86 | 50.78 | 63.76 | 26.91 | 24.90 | 20.92 | 36.85 |
| Tax % | 27.1% | 27.1% | 30.1% | 29.0% | 32.0% | 45.0% | 14.0% | — |
| Exceptional items | 1.48 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 6.98 | 22.94 | 35.89 | 44.89 | 17.96 | 13.96 | 17.95 | 27.93 |
| EPS (Rs) | 0.64 | 2.28 | 3.49 | 4.35 | 1.76 | 1.08 | 1.41 | 2.16 |
| Dividend payout % | 0.0% | 0.0% | 7.0% | 9.0% | 6.0% | 13.9% | 10.9% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8.02 | 8.02 | 8.02 | 10.02 | 10.03 | 13.03 | 13.03 |
| Reserves | 124 | 147 | 182 | 304 | 404 | 670 | 687 |
| Borrowings | 42.90 | 61.84 | 80.71 | 49.89 | 61.85 | 88.78 | 234 |
| Other Liabilities | 50.08 | 55.26 | 71.10 | 82.90 | 101 | 162 | 187 |
| Total Liabilities | 225 | 273 | 342 | 447 | 576 | 933 | 1,121 |
| Fixed Assets | 138 | 152 | 157 | 174 | 215 | 246 | 582 |
| CWIP | 4.01 | 2.01 | 5.01 | 28.01 | 68.07 | 289 | 96.03 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 38.10 | 0.00 | 0.00 |
| Other Assets | 82.83 | 119 | 181 | 246 | 255 | 398 | 445 |
| Inventories | 55.90 | 49.90 | 67.82 | 90.78 | 111 | 130 | 146 |
| Trade receivables | 10.98 | 59.96 | 96.92 | 129 | 107 | 174 | 205 |
| Cash & equivalents | 3.99 | 0.99 | 2.99 | 3.99 | 10.98 | 29.90 | 18.96 |
| Total Assets | 225 | 273 | 342 | 447 | 576 | 933 | 1,121 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 48.01 | 4.01 | 7.01 | 14.01 | 33.99 | −53.02 | 12.01 |
| Cash from investing activity | −38.87 | −20.93 | −16.96 | −59.78 | −116 | −200 | −160 |
| Cash from financing activity | −8.97 | 14.96 | 11.96 | 45.84 | 87.71 | 271 | 136 |
| Net cash flow | 0.00 | −2.01 | 2.01 | 1.01 | 7.01 | 18.01 | −12.01 |
| Capex | 39.01 | 21.01 | 17.03 | 60.01 | 79.02 | 252 | 160 |
| Free cash flow | 8.96 | −16.95 | −9.97 | −45.84 | −44.83 | −301 | −148 |
| CFO / OP % | 304.0% | 20.0% | 21.0% | 33.0% | 91.0% | −123.0% | 34.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 17 | 68 | 81 | 94 | 96 | 144 | 139 |
| Inventory days | 137 | 97 | 91 | 108 | 168 | 173 | 161 |
| Days payable | 59 | 89 | 73 | 69 | 98 | 125 | 152 |
| Cash conversion cycle | 95 | 76 | 99 | 132 | 166 | 193 | 148 |
| Working capital days | −13 | 20 | 31 | 89 | 93 | 123 | 116 |
| ROCE % | — | 20.0% | 25.0% | 22.0% | 8.0% | 5.0% | 5.0% |
For the Jun 2026 quarter, Bhagiradha Chemicals & Industries reported sales of ₹195 Cr, up 57.3% year on year and net profit of ₹12.97 Cr, up 225.1% year on year. The operating margin was 16.0%.
Bhagiradha Chemicals & Industries' sales for the year to Mar 2026 were ₹537 Cr; over the last twelve months they were ₹608 Cr.
Net profit for the year to Mar 2026 was ₹17.95 Cr, and ₹27.93 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.16.
Bhagiradha Chemicals & Industries reported borrowings of ₹234 Cr at Mar 2026, against cash and equivalents of ₹18.96 Cr.
Cash from operations was ₹12.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹148 Cr.